4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-066889
Chief Business Officer sold 11,000 shares at $30.39 ($334,294)
- Chief Business Officer acquired 11,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robb Gary Charles Chief Business Officer | 2024-05-28 | Option exercise 10b5-1 | +11,000 | $3.29 | $36,190 | 31,203 | D |
| Robb Gary Charles Chief Business Officer | 2024-05-28 | Sale 10b5-1 | −11,000 | $30.39 | $334,294 | 20,203 | D |
| Derivatives | |||||||
| Robb Gary Charles Chief Business Officer | 2024-05-28 | Option exercise · Stock option (right to buy) 10b5-1 | −11,000 | 50,037 | D | ||
| Open-market sales · 11,000 sh · avg $30.39 · $334,294 | |||||||
Loading xslF345X05/ownership.xml…